Nu Skin Enterprises - NUS Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NUS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NUS, but not buy additional shares or sell existing shares.
View NUS analyst ratings or view top-rated stocks.

3 Wall Street analysts have issued 12 month price targets for Nu Skin Enterprises' stock. Their NUS share price forecasts range from $40.00 to $75.00. On average, they expect the company's stock price to reach $58.50 in the next twelve months. This suggests a possible upside of 61.3% from the stock's current price.
View analysts price targets for NUS or view top-rated stocks among Wall Street analysts.

Nu Skin Enterprises' stock was trading at $50.75 at the beginning of the year. Since then, NUS stock has decreased by 28.5% and is now trading at $36.27.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 2nd 2022.
View our NUS earnings forecast.

Nu Skin Enterprises, Inc. (NYSE:NUS) posted its quarterly earnings results on Wednesday, November, 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.86 by $0.11. The company earned $641.15 million during the quarter, compared to analyst estimates of $639.19 million. Nu Skin Enterprises had a net margin of 4.57% and a trailing twelve-month return on equity of 19.78%. During the same quarter last year, the firm posted $1.08 EPS.

Nu Skin Enterprises declared a quarterly dividend on Thursday, August 4th. Stockholders of record on Friday, August 26th will be paid a dividend of $0.385 per share on Wednesday, September 7th. This represents a $1.54 annualized dividend and a yield of 4.25%. The ex-dividend date of this dividend is Thursday, August 25th.
Read our dividend analysis for NUS.

Nu Skin Enterprises (NYSE:NUS) pays an annual dividend of $1.54 per share and currently has a dividend yield of 4.23%. NUS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 21 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 69.37%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, NUS will have a dividend payout ratio of 41.96% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for NUS.

Nu Skin Enterprises updated its third quarter 2022 earnings guidance on Thursday, September, 1st. The company provided earnings per share (EPS) guidance of $0.70-$0.85 for the period, compared to the consensus estimate of $0.89. The company issued revenue guidance of $550.00 million-$590.00 million, compared to the consensus revenue estimate of $630.91 million.

72 employees have rated Nu Skin Enterprises Chief Executive Officer Ritch Wood on Glassdoor.com. Ritch Wood has an approval rating of 91% among the company's employees. This puts Ritch Wood in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Nu Skin Enterprises investors own include Alibaba Group (BABA), General Electric (GE), NVIDIA (NVDA), Marathon Petroleum (MPC), Gilead Sciences (GILD), Alphabet (GOOG), Tesla (TSLA), Herbalife Nutrition (HLF), Mastercard (MA) and Netflix (NFLX).

Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."

Nu Skin Enterprises' stock is owned by many different institutional and retail investors. Top institutional investors include State Street Corp (18.25%), Renaissance Technologies LLC (5.62%), AQR Capital Management LLC (1.69%), Aristotle Capital Boston LLC (1.65%), ProShare Advisors LLC (1.41%) and Northern Trust Corp (1.35%). Insiders that own company stock include Andrew D Lipman, D Matthew Dorny, Foulis Greg, James D Thomas, Jeffrey Clark Bettinger, Joseph Y Chang, Mark H Lawrence, Ritch N Wood, Ryan S Napierski and Steven Lund.
View institutional ownership trends.

Shares of NUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NUS stock can currently be purchased for approximately $36.27.

Nu Skin Enterprises (NYSE:NUS) has a market capitalization of $1.82 billion and generates $2.70 billion in revenue each year. The company earns $147.27 million in net income (profit) each year or $2.22 on an earnings per share basis.

The company employs 4,600 workers across the globe.

Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The official website for the company is www.nuskinenterprises.com. The company can be reached via phone at (801) 345-1000, via email at investorrelations@nuskin.com, or via fax at 801-345-5999.